Novel approaches to the treatment of depression by modulating the hypothalamic-pituitary-adrenal axis

Donna O'Brien, Kelly H. Skelton, Michael J. Owens, Charles Nemeroff

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Many patients with major depression show evidence of over-activation of the hypothalamic-pituitary-adrenal axis (HPA), as evidenced by hypercortisolism and adrenal hyperplasia. Such over-activity is associated with increased corticotropin releasing factor (CRF) reactivity in the CSF and blunted release of ACTH in response to CRF infusion. Recent evidence suggests a switch from CRF to AVP regulation of the axis during depression, with depressed patients showing enhanced response to ddAVP infusion. The HPA provides multiple potential sites for antidepressant development. The use of glucocorticoid antagonists, cortisol synthesis inhibitors, CRF and AVP antagonists have been suggested.

Original languageEnglish
Pages (from-to)89-93
Number of pages5
JournalHuman Psychopharmacology
Volume16
Issue number1
DOIs
StatePublished - Mar 27 2001
Externally publishedYes

Fingerprint

Corticotropin-Releasing Hormone
Cushing Syndrome
Therapeutics
Adrenocorticotropic Hormone
Antidepressive Agents
Glucocorticoids
Hyperplasia
Hydrocortisone

Keywords

  • Cortisol
  • Depression
  • Hypothalamic-pituitary-adrenal axis

ASJC Scopus subject areas

  • Pharmacology
  • Psychology(all)
  • Neuroscience(all)
  • Pharmacology (medical)
  • Psychiatry and Mental health
  • Neurology
  • Clinical Neurology

Cite this

Novel approaches to the treatment of depression by modulating the hypothalamic-pituitary-adrenal axis. / O'Brien, Donna; Skelton, Kelly H.; Owens, Michael J.; Nemeroff, Charles.

In: Human Psychopharmacology, Vol. 16, No. 1, 27.03.2001, p. 89-93.

Research output: Contribution to journalArticle

O'Brien, Donna ; Skelton, Kelly H. ; Owens, Michael J. ; Nemeroff, Charles. / Novel approaches to the treatment of depression by modulating the hypothalamic-pituitary-adrenal axis. In: Human Psychopharmacology. 2001 ; Vol. 16, No. 1. pp. 89-93.
@article{92fd7c4a26f64dcdb6741d7c643e6ef1,
title = "Novel approaches to the treatment of depression by modulating the hypothalamic-pituitary-adrenal axis",
abstract = "Many patients with major depression show evidence of over-activation of the hypothalamic-pituitary-adrenal axis (HPA), as evidenced by hypercortisolism and adrenal hyperplasia. Such over-activity is associated with increased corticotropin releasing factor (CRF) reactivity in the CSF and blunted release of ACTH in response to CRF infusion. Recent evidence suggests a switch from CRF to AVP regulation of the axis during depression, with depressed patients showing enhanced response to ddAVP infusion. The HPA provides multiple potential sites for antidepressant development. The use of glucocorticoid antagonists, cortisol synthesis inhibitors, CRF and AVP antagonists have been suggested.",
keywords = "Cortisol, Depression, Hypothalamic-pituitary-adrenal axis",
author = "Donna O'Brien and Skelton, {Kelly H.} and Owens, {Michael J.} and Charles Nemeroff",
year = "2001",
month = "3",
day = "27",
doi = "10.1002/hup.188",
language = "English",
volume = "16",
pages = "89--93",
journal = "Human Psychopharmacology",
issn = "0885-6222",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Novel approaches to the treatment of depression by modulating the hypothalamic-pituitary-adrenal axis

AU - O'Brien, Donna

AU - Skelton, Kelly H.

AU - Owens, Michael J.

AU - Nemeroff, Charles

PY - 2001/3/27

Y1 - 2001/3/27

N2 - Many patients with major depression show evidence of over-activation of the hypothalamic-pituitary-adrenal axis (HPA), as evidenced by hypercortisolism and adrenal hyperplasia. Such over-activity is associated with increased corticotropin releasing factor (CRF) reactivity in the CSF and blunted release of ACTH in response to CRF infusion. Recent evidence suggests a switch from CRF to AVP regulation of the axis during depression, with depressed patients showing enhanced response to ddAVP infusion. The HPA provides multiple potential sites for antidepressant development. The use of glucocorticoid antagonists, cortisol synthesis inhibitors, CRF and AVP antagonists have been suggested.

AB - Many patients with major depression show evidence of over-activation of the hypothalamic-pituitary-adrenal axis (HPA), as evidenced by hypercortisolism and adrenal hyperplasia. Such over-activity is associated with increased corticotropin releasing factor (CRF) reactivity in the CSF and blunted release of ACTH in response to CRF infusion. Recent evidence suggests a switch from CRF to AVP regulation of the axis during depression, with depressed patients showing enhanced response to ddAVP infusion. The HPA provides multiple potential sites for antidepressant development. The use of glucocorticoid antagonists, cortisol synthesis inhibitors, CRF and AVP antagonists have been suggested.

KW - Cortisol

KW - Depression

KW - Hypothalamic-pituitary-adrenal axis

UR - http://www.scopus.com/inward/record.url?scp=0035107840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035107840&partnerID=8YFLogxK

U2 - 10.1002/hup.188

DO - 10.1002/hup.188

M3 - Article

VL - 16

SP - 89

EP - 93

JO - Human Psychopharmacology

JF - Human Psychopharmacology

SN - 0885-6222

IS - 1

ER -